$QFIN

Why is Qfin Holdings stock plummeting today?

Qfin Holdings (QFIN) stock fell 17.6% to $9.50 after reporting Q2 2026 revenue of RMB 3.57B, missing estimates and down 31.6% YoY. Profit dropped to RMB 455M. Analysts downgraded the stock, citing liquidity challenges and weak loan volume. The S&P 500, Dow, and Nasdaq were flat, indicating the decline is company-specific.

Original reporting
Published Aug 26, 2026, 4:12 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 26, 2026, 4:25 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$QFIN
Bearish
high confidence
Mentioned
$QFIN
Relevance
8/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$QFINBearishHigh
01

Why it matters

The earnings miss and analyst downgrades drove a 17.6% intraday decline, setting a new 52‑week low.

02

Market read

The report underscores heightened risk in Chinese consumer credit, affecting sector sentiment.

03

What to watch

Potential government stimulus or policy easing could improve loan demand later.

Relevance 8/10Novelty 8/10Timing: mid‑day today

Background

Qfin Holdings is a China‑focused fintech lender listed on NASDAQ.

Company-level read

Ticker impact

$QFINBearishHigh confidence
Context

Qfin Holdings reported Q2 2026 results with revenue down 31.6% YoY and a 17.6% share drop, triggering multiple analyst downgrades.

Expected impact

Further downside pressure likely unless guidance improves.

Evidence & confidence

Revenue miss, profit plunge, and analyst downgrades create a clear bearish catalyst.

Market effects

Highlights stress in China's consumer credit and fintech lending sector.

May weigh on other Chinese fintech stocks and broader Asian markets.

Limited; primarily a regional credit‑market concern.

Counterpoint

If the revenue dip is temporary, the stock could rebound on a short‑cover rally.

Key entities

  • Citi

    Downgraded QFIN to Sell and cut price target to $8.

  • JPMorgan

    Moved to Underweight with a $9 price target.

Related articles

$QFINMed

Why is Qfin stock sliding today?

Qfin Holdings shares fell 3.7% to $12.33 ahead of its Q2 2026 results due tomorrow. Investing.com cites analyst expectations for about a 44% year-over-year EPS decline and lower revenue, tied to China consumer credit pressures and fintech regulation. JPMorgan kept a Neutral rating and cut its price target to $13.50 from $14.50.

$QFINHighAI 9/10

Qfin (NASDAQ:QFIN) Shares Gap Up After Better

Qfin Holdings (NASDAQ:QFIN) shares rose before Wednesday trading after earnings beat expectations. The stock closed at $12.59 and opened at $13.90. Qfin reported EPS of $1.04 vs $0.96 consensus and revenue of $567.01M vs $476.92M. Analysts cited mixed ratings; MarketBeat shows “Reduce” consensus and $22.20 average target.

$QFINHighAI 9/10

Qfin Holdings Q1 Profit Down; Sees Decline In Q2 Earnings; But Stock Up

Qfin Holdings (3660.HK) reported Q1 net income attributable to ordinary shareholders of 883.32 million yuan ($128.06m), down from 1.80 billion yuan a year earlier, with quarterly revenue falling to 3.91 billion yuan. The company forecast Q2 net income of 830–910 million yuan, down 47%–51% y/y, citing weaker credit demand and regulatory uncertainty. Shares rose 6.84% to HK$49.980.

$QFINHighAI 9/10

Qfin Holdings Announces First Quarter 2026 Unaudited Financial Results

Qfin Holdings reported first-quarter 2026 unaudited results for the period ended March 31, 2026. Total net revenue was RMB3,909.3 million (US$566.7 million) and net income RMB879.8 million (US$127.5 million); non-GAAP net income was RMB945.9 million. Loan facilitation/origination volume fell 26.8% to RMB65,034 million and outstanding loan balance fell 18.5% to RMB114,387 million. The 90-day+ delinquency rate was 3.50%.

$CNRHighAI 8/10

RBC Capital Names Top 30 Global Stock Ideas for 2026

RBC Capital updated its Top 30 Global Ideas list for 2026, adding Apotex Health, Canadian National Railway (CNR), and Lonza (LONN). The list delivered an 11.1% return in Q2/26. CNR reported Q2/26 earnings of C$2.08 per share on $4.75B revenue, raising its full-year guidance. RBC highlights CNR's discount valuation, Apotex's market share, and Lonza's growth potential.

$TGTHighAI 9/10

Target (TGT) Q2 2026 Earnings Call Transcript

Target (TGT) reported Q2 2026 net sales of $26.5B, up 5.3% YoY, with EPS of $4.11, a 100% increase due to tariff refunds. Digital sales rose 8.7%, while store sales grew 2.7%. The company raised full-year guidance, expecting 5% sales growth and EPS of $9.90-$10.90. Management highlighted growth in snacks, beauty, and digital traffic, but noted challenges in home and apparel categories.